Get started
Author

Susana Torres‐Martínez

Observed names: Susana Martinez, Susana Martínez, Susana Torres, Susana Torres Martinez, Susana Torres Martínez, Susana Torres-Martinez, Susana Torres-Martínez, Torres S
Observed institutions: Universitat de Miguel Hernández d'Elx, Universitat de València, Instituto de Salud Carlos III, Valencian International University, Hospital Universitari i Politècnic La Fe, Centro de Investigación Biomédica en Red, Fundacio Investigacio Hospital General Universitari De Valencia, Hospital General Universitario De Valencia, Hospital de Mataró, Centro de Investigación Biomédica en Red de Cáncer, Centro de Investigacion Principe Felipe, Carlos III Hospital, Centro de Investigación Médica Aplicada, Universitat Politècnica de València
ORCID: 0000-0001-8366-8337
Observed ORCID: 0000-0001-8366-8337
OpenAlex ID: A5000172334
Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders
2018 · Sonia Herraiz, Mónica Romeu, et al. · Fertility and Sterility · 139
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
2021 · Cora Palanca-Ballester, Aitor Rodriguez-Casanova, et al. · Cancers · 85
PDF
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study
2018 · Begoña Martin-Castillo, Sonia Pernas, et al. · Oncotarget · 77
PDF
Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
2022 · Martín Núñez Abad, Silvia Calabuig-Fariñas, et al. · Cancers · 68
PDF
3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study
2021 · Alejandro Herreros-Pomares, Xuan Zhou, et al. · Materials Science and Engineering C · 63
Malignant mesothelioma: New insights into a rare disease
2012 · Jordi Remon, Pilar Lianes, et al. · Cancer Treatment Reviews · 46
Update on systemic treatment in early triple negative breast cancer
2021 · Martín Núñez Abad, Silvia Calabuig-Fariñas, et al. · Therapeutic Advances in Medical Oncology · 44
PDF
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer
2020 · Susana Torres, Álvaro González, et al. · Expert Review of Molecular Diagnostics · 42
Exosomal microRNAs in non-small cell lung cancer
2021 · Elena Duréndez-Sáez, Susana Torres-Martinez, et al. · Translational Cancer Research · 41
Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin
2013 · Sílvia Cufí, Bruna Corominas-Faja, et al. · Oncotarget · 36
PDF
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
2019 · Elisabet Cuyàs, Salvador Fernández-Arroyo, et al. · Aging · 34
PDF
Factors Associated With Mitochondrial Dysfunction in Circulating Peripheral Blood Lymphocytes From HIV-Infected People
2003 · Rosa Polo, Susana Martinez, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 34
Brain metastases from renal cell carcinoma. Should we change the current standard?
2011 · Jordi Remon, Pilar Lianes, et al. · Cancer Treatment Reviews · 32
The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
2019 · Elisabet Cuyàs, Maria Buxó, et al. · Frontiers in Oncology · 27
PDF
Adjuvant treatment in resected non-small cell lung cancer: Current and future issues
2013 · Jordi Remon, Pilar Lianes, et al. · Critical Reviews in Oncology/Hematology · 23
Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer
2019 · Eugeni Lopez-Bonet, Maria Buxó, et al. · Journal of Clinical Medicine · 16
PDF
Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer
2022 · Elena Duréndez-Sáez, Silvia Calabuig-Fariñas, et al. · Cancers · 15
PDF
Soluble galectin‐3 as a microenvironment‐relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma
2023 · Susana Torres‐Martínez, Silvia Calabuig‐Fariñas, et al. · Molecular Oncology · 12
PDF
Passenger mutations in cancer evolution
2019 · Aparisi F, Amado-Labrador H, et al. · Cancer Reports and Reviews · 11
PDF
Induction of viral interference by IPNV-carrier cells on target cells: A cell co-culture study
2016 · Ricardo Parreño, Susana Torres, et al. · Fish & Shellfish Immunology · 5
PDF
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer
2023 · Susana Torres-Martínez, Silvia Calabuig-Fariñas, et al. · International Journal of Molecular Sciences · 4
PDF
Diagnostic and Prognostic Value of Angiogenic Status in Hereditary Hemorrhagic Telangiectasia
2024 · Sherlyne Jaimes-Díaz, Gustavo Juan-Samper, et al. · Diagnostics · 2
PDF
Liquid biopsy for monitoring response in KRAS-mutated NSCLC patients treated with first-line immunotherapy
2024 · Ester Munera-Maravilla, Susana Torres-Martínez, et al. · The Journal of Liquid Biopsy · 1
PDF
Soluble biomarker signature to predict outcome of patients with non-small-cell lung cancer (NSCLC) treated with anti-PD1/PDL1 monoclonal antibodies.
2019 · Javier Garde-Noguera, Eloisa Jantus-Lewintre, et al. · Journal of Clinical Oncology · 1
P5. A dual osteoclastic and metalloproteolytic mechanism is required for bone colonization in lung cancer metastasis
2008 · Diego Luis-Ravelo, Silvestre Vicent, et al. · Cancer Treatment Reviews · 1
Works count: 40
Citation count: 859
H-index: 16
I10-index: 19
Year
Topic
Type